Combination of Geniposide and Eleutheroside B Exerts Antidepressant-Like Effect on Lipopolysaccharide-Induced Depression Mice Model

Bo ZHANG; Hong-sheng CHANG; Kai-li HU; Xue YU; Li-na LI; Xiang-qing XU

doi:10.1007/s11655-019-3051-5

Your Location：

Home >

Browse articles >

Combination of Geniposide and Eleutheroside B Exerts Antidepressant-Like Effect on Lipopolysaccharide-Induced Depression Mice Model

Original Article | Updated：2021-09-01

- Combination of Geniposide and Eleutheroside B Exerts Antidepressant-Like Effect on Lipopolysaccharide-Induced Depression Mice Model
- Chinese Journal of Integrative Medicine Vol. 27, Issue 7, Pages: 534-541(2021)
- Affiliations：
  
  1.School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing (102488), China
  2.School of Basic Medicine Science, Beijing University of Chinese Medicine, Beijing (100102), China
  3.Experiment Center, Encephalopathy Department, Affiliated Hospital of Shandong University of Chinese Medicine, Jinan (250014), China
- Author bio：
  
  Associate Prof. XU Xiang-qing, E-mail:happyxiangqing@163.com
- Funds：
- DOI：10.1007/s11655-019-3051-5
  CLC：
- Published：01 July 2021，
  
  Published Online：29 November 2019，
  
  Accepted：22 April 2019
Scan for full text
Bo ZHANG, Hong-sheng CHANG, Kai-li HU, et al. Combination of Geniposide and Eleutheroside B Exerts Antidepressant-Like Effect on Lipopolysaccharide-Induced Depression Mice Model. [J]. Chinese Journal of Integrative Medicine 27(7):534-541(2021)
DOI：

Bo ZHANG, Hong-sheng CHANG, Kai-li HU, et al. Combination of Geniposide and Eleutheroside B Exerts Antidepressant-Like Effect on Lipopolysaccharide-Induced Depression Mice Model. [J]. Chinese Journal of Integrative Medicine 27(7):534-541(2021) DOI： 10.1007/s11655-019-3051-5.

摘要

Abstract

Objective:

To study the antidepressant-like effect and action mechanism of geniposide and eleutheroside B combination treatment on the lipopolysaccharide (LPS)-induced depression mice model.

Methods:

Depression mice model was established by lipopolysaccharide (LPS) injection. Totally 48 mice were randomly divided into 6 groups (8 rats per group) according to a random number table

including normal

model

fluoxetine (20 mg/kg)

geniposide (100 mg/kg) + eleutheroside B (100 mg/kg)

geniposide + eleutheroside B + WAY 100635 (0.03 mg/kg)

geniposide + eleutheroside B+ N-methyl-D-aspartic acid receptor (NMDA

75 mg/kg) groups

respectively. After continuous administration for 10 days

autonomic activity tests after 30 min of administration were performed on the 10th day. On the 11th day

except for the normal group

the mice in the other groups were intraperitoneally injected with LPS (1 mg/kg)

and the behavioral tests were performed 4 h later. Enzyme linked immunosorbent assay was used to detect tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) levels in mice serum. The mRNA expression of indoleamine 2

3-dioxygenase (IDO) and nuclear transcription factor (NF-κB) were detected by real-time quantitative polymerase chain reaction. Western-blot analysis was used to detect IDO and NF-κB protein expressions in hippocampus tissue.

Results:

Compared with the normal group

a single administration of LPS increased the immobility time in the forced swimming test (FST) and tail suspension test (TST

0.01)

without affecting autonomous activity. Compared with the model group

fluoxetine and geniposide + eleutheroside B administration significantly improved the immobility time of depressed mice in the FST and TST

decreased serum IL-1β content

inhibited the expression levels of NF-κB gene and protein in hippocampus tissues (

0.05 or

0.01). Compared with the model group

geniposide + eleutheroside B treatment significantly reduced serum TNF-α content and inhibited IDO mRNA and protein expressions in hippocampus (

0.05 or

0.01). In addition

NMDA partly prevented the inhibition of IDO mRNA expression by geniposide + eleutheroside B; NMDA and WAY-100635 also partly prevented the reduction of IL-1β content induced by geniposide + eleutheroside B treatment (

0.05 or

0.01).

Conclusions:

The combination of geniposide and eleutheroside B showed a certain antidepression-like effect. Its main mechanism of action may be contributed to inhibiting the activation of NF-κB

decreasing the proinflammatory cytokines such as TNF-α

IL-1β

and inhibiting in the neuroinflammatory reaction. Additionally

it also affects tryptophan metabolism

reduces the expression of a key enzyme of tryptophan metabolism

IDO. And this antidepressant-like effect may be mediated by 5-hydroxytryptamine and glutamate systems.

关键词

Keywords

geniposideeleutheroside Bantidepressant effectmechanism5-hydroxytryptamineglutamate

references

RJ Baldessarini. The basis for amine hypotheses in affective disorders: a critical evaluation. Arch Gen Psychiatry 1975;32:1087-1093.

CU Correll, J Detraux, LJ De, HM De. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119-136.

C Stetler, GE Miller. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011;73:114.

BE Leonard. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr 2017;30:1.

XQ Xu, CC Zong. A theoretical study on the treatment of depression with the method of 'Purging Heart fire and nourishing Kidney water'. Chin J Basic Med Tradit Chin Med (Chin) 2015;25:393-394.

XQ Xu. Therapeutic effect of Eleutheroside senticosus combined with Gardenia on elderly patients with depressive disorder J. Chin J Gerontol (Chin) 2012;32:5383-5384.

XH Wei, XM Cheng, JS Shen, ZT Wang. Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. J Ethnopharmacol 2008;117:339-344.

AM Yao, FF Ma, LL Zhang, F Feng. Effect of aqueous extract and fractions of Zhi-Zi-Hou-Po Decoction against depression in inescapable stressed mice: restoration of monoamine neurotransmitters in discrete brain regions.Pharm Biol 2013;51:213-220.

L Zhou, MN Wang, X Zhu, H Cheng, YX Wang, F Du, et al. Active ingredients, pharmacological actions, and clinical applications of acanthopanax in the central nervous system.J Hunan Univ Chin Med (Chin) 2018;38:961-964.

HJ Koo, YS Song, HJ Kim, YH Lee, SM Hong, SJ Kim, et al. Anti-inflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 2004;495:201-208.

C Zhao, H Zhang, H Li, C Lv, X Liu, Z Li, et al. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice. Neuropharmacology 2017;116:18-29.

X Gong, L Zhang, R Jiang, CD Wang, XR Yin, JY Wan.Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Appl Toxicol 2014;34:265-271.

L Huang, H Zhao, B Huang, C Zheng, W Peng, L Qin.Acanthopanax senticosus: review of botany, chemistry and pharmacology. Pharmazie 2011;66:83-97.

A Zhang, Z Liu, L Sheng, H Wu. Protective effects of syringin against lipopolysaccharide-induced acute lung injury in mice. J Surg Res 2017;209:252-257.

Y Zhao, H Li, F Fang, T Qin, W Xiao, Z Wang, et al.Geniposide improves repeated restraint stress-induced depression-like behavior in mice by ameliorating neuronal apoptosis via regulating GLP-1R/AKT signaling pathway.Neurosci Lett 2018;676:19-26.

Y Zhou, C Cheng, D Baranenko, J Wang, Y Li, W Lu.Effects of Acanthopanax senticosus on brain injury induced by simulated spatial radiation in mouse model based on pharmacokinetics and comparative proteomics. Int J Mol Sci 2018;19:159.

X Zhao, F Cao, Q Liu, X Li, G Xu, G Liu, et al. Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mice models of depression. Behav Brain Res 2019;34:494-502.

GX Zhang, BH Sun. Research on independent activity patterns of mice. Chin Pharmacol Bull 2002;18:464-465.

RD Porsolt. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacolodyn 1977;229:327.

L Steru, R Chermat, B Thierry, P Simon. The tail suspension test: a new method for screening antidepressants in mice.Psychopharmacology 1985;85:367.

C Alexander, ET Rietschel. Invited review: bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001;7:167-202.

MS Hosseinizare, F Gu, A Abdulla, S Powell, J Žiburkus.Effects of experimental traumatic brain injury and impaired glutamate transport on cortical spreading depression. Exp Neurol 2017;295:155-161.

M Hamon, L Lanfumey, MS El, C Boni, MC Miquel, F Bolaños, et al. The main features of central 5-HT1 receptors.Neuropsychopharmacol 1990;3:349.

A Francesc. Serotonin receptors involved in antidepressant effects. Pharmacol Therapeut 2013;137:119-131.

CP Müller, RJ Carey, JP Huston, MA De Souza Silva.Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol 2007;81:133-178.

SC Cheetham, MR Crompton, CL Katona, RW Horton. Brain 5-HT1 binding sites in depressed suicides.Psychopharmacology 1990;102:544.

D Choi. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634.

GP Gasic, M Hollmann. Molecular neurobiology of glutamate receptors. Annu Rev Physiol 1992;54:507.

Esra Kü, ZS Melek, C Mecit, KK Okan, M Cüneytü. G Zafer.The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur J Clin Pharmacol 2009;65:571-577.

B Pochwat, A Paucha-Poniewiera, B Szewczyk, A Pilc, G Nowak. NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin Inv Drug 2014;23:1181-1192.

AS Jacoby, K Munkholm, M Vinberg, BK Pedersen, L Kessing. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar Ⅰ disorder—results from a prospective study. J Affect Disorders 2016;197:167-174.

A Hoffmann, D Baltimore. Circuitry of nuclear factor κB signaling. Immunol Rev 2006;210:171-186.

W Li, BP Katz, SM Spinola. Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase via type Ⅰ interferons and tumor necrosis factor alpha in human dendritic cells. Infect Immun 2011;79:3338-3347.

M Maes, I Mihaylova, MD Ruyter, M Kubera, EJNEL Bosmans. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett 2007;28:826-831.

MD Lovelace, B Varney, G Sundaram, MJ Lennon, KL Chai, K Jacobs, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 2017;112(Pt B):373-388.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Electroacupuncture at Sensitized Acupoints Relieves Somatic Referred Pain in Colitis Rats by Inhibiting Sympathetic-Sensory Coupling to Interfere with 5-HT Signaling Pathway

Mechanism Study on Chinese Medicine in Treatment of Nodular Goiter

Beneficial Effects and Potential Mechanisms of Tai Chi on Lower Limb Osteoarthritis: A Biopsychosocial Perspective

Mechanism of Shengmai Injection on Anti-Sepsis and Protective Activities of Intestinal Mucosal Barrier in Mice

Cupping Therapy for Diseases: An Overview of Scientific Evidence from 2009 to 2019

Related Author

No data

Related Institution

Department of Neurology, the First Affiliated Hospital of Chengdu Medical College

Department of Rehabilitation Medicine, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University

Department of Rehabilitation Medicine, the First Affiliated Hospital of Chengdu Medical College

School of Clinical Medicine, Chengdu Medical College

Youth Research and Innovation Team of Pharmacology of Liver Viscera in Emotional Disease and Syndromes

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰